title: A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risks.
abstract: Anticoagulant drugs maintain a high potential for adverse events due to their inherent risk of haemorrhage and/or complex pharmacology. In addition, compromising the safety of these agents is the context in which they are principally used; that is, in the long-term prevention of thromboembolic diseases in an older patient population. These challenges are especially pronounced in the prevention of stroke in older persons with atrial fibrillation (AF), where the need for thromboprophylaxis is paramount and in whom the arrhythmia is most prevalent, but where the target population is simultaneously at high risk of adverse drug events. Essentially, this translates to the use of high-risk therapies on an indefinite basis, in persons who have multiple comorbidities, use polypharmacy, and who may have age-related functional and cognitive decline, culminating in a higher potential for medication misadventure. For this reason, anticoagulants mandate extra pharmacovigilance, and therefore the aim of this review is to address some of the key safety considerations in the use of anticoagulant drugs (warfarin, dabigatran, rivaroxaban), spanning the initiation of therapy to its ongoing management. Using the Medication Management Pathway (MMP) as a framework, in this review we canvas and highlight specific developments in practical strategies to facilitate the safe use of anticoagulants (particularly warfarin) in 'at-risk' elderly patients including: comprehensive risk/benefit assessment using novel risk stratification tools; focused medicines review services; therapeutic drug monitoring services delivered in the primary care setting; and practical education strategies and resources targeting the older patient population. Until newer alternative anticoagulants become viable options for widespread use, clinicians will necessarily need to rely on specific resources and interventions to facilitate the safe use of currently available anticoagulants (i.e. warfarin) in 'at-risk' older people.
authors.affiliation: Faculty of Pharmacy, A15 Science Road, University of Sydney, NSW 2163, Australia; Northern Sydney Central Coast Health Service - Clinical Pharmacology, Level 11 (11C) Main Block, Royal North Shore Hospital, Reserve Road, St Leonards, NSW, Australia.
authors.forename: Beata
authors.initials: B
authors.lastname: Bajorek
keywords: anticoagulant; atrial fibrillation; medication safety; medicines management pathway; risk assessment; risk–benefit assessment; stroke prevention; warfarin
references.citation: Circulation. 2004 Oct 19;110(16):2287-92
references.pmid: 15477396
references.citation: J Am Coll Cardiol. 2011 Jan 11;57(2):173-80
references.pmid: 21111555
references.citation: Ann Pharmacother. 2009 Jun;43(6):1096-106
references.pmid: 19470856
references.citation: Med J Aust. 2007 Feb 19;186(4):175-80
references.pmid: 17309417
references.citation: J Am Geriatr Soc. 2005 Nov;53(11):1912-20
references.pmid: 16274372
references.citation: J Am Coll Cardiol. 2008 Feb 26;51(8):810-5
references.pmid: 18294564
references.citation: Am Heart J. 2010 Oct;160(4):635-41
references.pmid: 20934556
references.citation: Lancet. 2007 Aug 11;370(9586):493-503
references.pmid: 17693178
references.citation: Pharm Pract (Granada). 2011 Jan;9(1):1-10
references.pmid: 25132883
references.citation: Int J Clin Pharm. 2012 Feb;34(1):88-97
references.pmid: 22179941
references.citation: Lancet. 2011 Jan 1;377(9759):31-41
references.pmid: 21144578
references.citation: Am J Med. 1998 Aug;105(2):91-9
references.pmid: 9727814
references.citation: Am Heart J. 2006 Mar;151(3):713-9
references.pmid: 16504638
references.citation: BMJ. 1999 May 15;318(7194):1324-7
references.pmid: 10323820
references.citation: Arch Phys Med Rehabil. 1995 Sep;76(9):840-3
references.pmid: 7668955
references.citation: Lancet. 1989 Jan 28;1(8631):175-9
references.pmid: 2563096
references.citation: J Eval Clin Pract. 2011 Feb;17(1):104-10
references.pmid: 20722881
references.citation: Thromb Res. 2007;121(3):347-52
references.pmid: 17597186
references.citation: Arch Intern Med. 2010 Sep 13;170(16):1433-41
references.pmid: 20837828
references.citation: J Am Geriatr Soc. 2006 Aug;54(8):1231-6
references.pmid: 16913990
references.citation: Am Heart J. 2010 Mar;159(3):348-353.e1
references.pmid: 20211294
references.citation: Ann Pharmacother. 2008 Apr;42(4):523-32
references.pmid: 18334606
references.citation: Ann Intern Med. 2011 Jan 4;154(1):1-11
references.pmid: 21041570
references.citation: Lancet. 2010 Sep 18;376(9745):975-83
references.pmid: 20801496
references.citation: Ann Intern Med. 2007 Jun 19;146(12):857-67
references.pmid: 17577005
references.citation: Lancet. 2006 Feb 4;367(9508):404-11
references.pmid: 16458764
references.citation: Cardiol Clin. 2008 May;26(2):157-67, v
references.pmid: 18406992
references.citation: JAMA. 1994 Mar 16;271(11):840-4
references.pmid: 8114238
references.citation: J Thromb Haemost. 2008 Sep;6(9):1500-6
references.pmid: 18573187
references.citation: Arch Intern Med. 1999 Mar 8;159(5):457-60
references.pmid: 10074953
references.citation: Chest. 2010 Nov;138(5):1093-100
references.pmid: 20299623
references.citation: Age Ageing. 2005 Jan;34(1):1-3
references.pmid: 15591476
references.citation: Chest. 2006 Nov;130(5):1296-9
references.pmid: 17099002
references.citation: Stroke. 2009 Jan;40(1):235-40
references.pmid: 18757287
references.citation: Ann Neurol. 1984 Nov;16(5):553-8
references.pmid: 6508238
references.citation: J Am Coll Cardiol. 2010 Sep 7;56(11):827-37
references.pmid: 20813280
references.citation: N Engl J Med. 1990 Nov 29;323(22):1505-11
references.pmid: 2233931
references.citation: Clin Interv Aging. 2010 May 25;5:157-62
references.pmid: 20517485
references.citation: Thromb Res. 2009 May;124(1):37-41
references.pmid: 19062079
references.citation: Stroke. 2009 Jan;40(1):5-7
references.pmid: 18757283
references.citation: Stroke. 2005 Jul;36(7):1588-93
references.pmid: 15947271
references.citation: Arch Intern Med. 1993 Jul 12;153(13):1557-62
references.pmid: 8323419
references.citation: Lancet. 2007 Nov 10;370(9599):1608; author reply 1608
references.pmid: 17993359
references.citation: Chest. 2006 Nov;130(5):1390-6
references.pmid: 17099015
references.citation: Arch Intern Med. 2007 Feb 12;167(3):246-52
references.pmid: 17296879
references.citation: Thromb J. 2005 Jan 07;3(1):1
references.pmid: 15638939
references.citation: Arch Intern Med. 1999 Apr 12;159(7):677-85
references.pmid: 10218746
references.citation: Blood Coagul Fibrinolysis. 2009 Jan;20(1):47-51
references.pmid: 20523164
references.citation: Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):84-91
references.pmid: 20031794
references.citation: Arch Intern Med. 2005 Jul 11;165(13):1527-32
references.pmid: 16009869
references.citation: Circulation. 1991 Aug;84(2):527-39
references.pmid: 1860198
references.citation: Eur J Intern Med. 2010 Dec;21(6):516-23
references.pmid: 21111937
references.citation: Arch Intern Med. 2001 Sep 24;161(17):2125-8
references.pmid: 11570942
references.citation: Stroke. 2008 Jan;39(1):227-30
references.pmid: 18048861
references.citation: Eval Health Prof. 2010 Sep;33(3):276-301
references.pmid: 20801973
references.citation: Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):1885-9
references.pmid: 20671233
references.citation: Age Ageing. 2009 Mar;38(2):156-62
references.pmid: 19151165
references.citation: Age Ageing. 2001 May;30(3):205-11
references.pmid: 11443021
references.citation: Eur Heart J. 2010 Oct;31(19):2369-429
references.pmid: 20802247
references.citation: Am Heart J. 2010 Mar;159(3):340-347.e1
references.pmid: 20211293
references.citation: Stroke. 1991 Aug;22(8):983-8
references.pmid: 1866765
references.citation: Chest. 2010 Feb;137(2):263-72
references.pmid: 19762550
references.citation: Australas J Ageing. 2012 Jun;31(2):102-9
references.pmid: 22676169
references.citation: Thromb Haemost. 2010 Mar;103(3):572-85
references.pmid: 20135071
references.citation: J Interv Card Electrophysiol. 2009 Jun;25(1):19-23
references.pmid: 19148730
references.citation: Stroke. 2004 Jan;35(1):116-21
references.pmid: 14671247
references.citation: Circulation. 2008 Nov 11;118(20):2029-37
references.pmid: 18955670
references.citation: N Engl J Med. 2009 Sep 17;361(12):1139-51
references.pmid: 19717844
references.citation: Am J Med. 2005 Jun;118(6):612-7
references.pmid: 15922692
references.citation: Age Ageing. 2007 Mar;36(2):151-6
references.pmid: 17175564
references.citation: Cardiovasc Ther. 2010 Oct;28(5):295-301
references.pmid: 20718760